THERAXEN

Welcome to the Brand page for “THERAXEN”, which is offered here for Biomedical services, research, development, and product design for pharmaceutical products involved in the diagnosis and treatment of human diseases; biomedical services, pharmaceutical research and development, modeling and testing of pharmaceuticals and cancer diagnostic and treatment therapies; biomedical and laboratory services, biologic assay development, preclinical pharmaceutical research, clinical research, clinical trial management, and providing in silico screening and in vitro testing of small molecules targeting guanine nucleotide exchange factors (gefs), all for pharmaceutical product research, discovery, and development purposes; consulting and advising on scientific research in the fields of small molecules and drug discovery;.

Its status is currently believed to be active. Its class is unavailable. “THERAXEN” is believed to be currently owned by “Emmanuelle Meuillet”.